USP General Chapter 797 governs sterile compounding across hospital and outpatient pharmacies preparing injectable, ophthalmic, and other sterile medications, with requirements considerably more detailed and specific than a general institutional commitment to "sterile technique" — genuine compliance depends on understanding and implementing these specific requirements rather than assuming good general pharmacy practice automatically satisfies the standard.
Risk-Level Categorization Determines Which Specific Requirements Apply
USP 797 categorizes compounded sterile preparations into risk levels based on factors including the number of sterile products combined, the compounding process complexity, and storage duration before use, with each risk level carrying distinct requirements for environmental conditions, personnel qualification, and beyond-use dating — a pharmacy must correctly categorize each compounded preparation to apply the appropriate requirement tier, since applying a lower-risk category's less stringent requirements to a preparation that actually meets higher-risk criteria represents a genuine compliance failure with real patient safety implications.
Environmental Monitoring Requirements Extend Well Beyond a Clean-Looking Workspace
The standard requires specific, documented environmental monitoring — viable and non-viable particle counts, surface sampling, and personnel glove-tip sampling — performed at defined intervals, not simply visual confirmation that a compounding area appears clean. This monitoring is designed to catch environmental contamination that would not be visually apparent, reflecting that sterile compounding safety depends on microbiological conditions invisible to casual visual inspection.
Personnel Competency Requires Initial and Ongoing Demonstrated Evaluation
USP 797 requires personnel performing sterile compounding to complete initial competency evaluation, including media-fill testing (a simulated compounding process using growth media to detect any contamination introduced during the compounder's actual technique), along with periodic ongoing competency reassessment — this is a demonstrated skills evaluation requirement, not simply completion of a training course or certification credential, reflecting that sterile technique competency can degrade over time without this kind of periodic verification.
Beyond-Use Dating Reflects Genuine Sterility Assurance, Not Arbitrary Timeframes
Beyond-use dates assigned to compounded sterile preparations are determined by the specific risk level category and storage conditions, reflecting the actual sterility assurance the compounding process and environment can support — extending a beyond-use date beyond what the applicable risk-level category permits, even if the preparation appears visually unchanged, represents a direct compliance violation with genuine patient safety stakes given that visual appearance does not reliably indicate microbiological safety.
Facility Design and Engineering Controls Require Specific Certification
Sterile compounding facilities require specific engineering controls — primary engineering controls like laminar airflow hoods, and appropriately designed cleanroom or segregated compounding areas — that must be certified by qualified personnel at defined intervals, not simply installed once and assumed to remain compliant indefinitely. Equipment performance can degrade over time, making this recurring certification requirement a genuine ongoing compliance obligation rather than a one-time installation checkbox.
Documentation Creates the Audit Trail That Demonstrates Actual Compliance
Comprehensive documentation of environmental monitoring results, personnel competency evaluations, and equipment certification creates the audit trail that allows both internal quality assurance and external regulatory review to actually verify compliance — a facility that performs all the required activities but maintains inadequate documentation faces genuine compliance risk during inspection, since demonstrated compliance depends on documented evidence, not simply the underlying activities having occurred.
Conclusion
USP 797 compliance depends on correct risk-level categorization, rigorous environmental monitoring, demonstrated personnel competency, accurate beyond-use dating, and certified engineering controls — a considerably more detailed and technical standard than general sterile technique awareness alone satisfies. Facilities maintaining sterile compounding programs depend on properly certified pharmacy compounding equipment to support genuine compliance.
